Abstract. MIRANDA GARCIA, Mª C.. Extended spectrum beta-lactamase – positive Escherichia coli: resistance. Sanid. Mil. [online]. , vol, n.4, pp Tratamiento de las infecciones por microorganismos productores de betalactamasas de espectro extendido: un nuevo reto terapéutico. Prevalencia de betalactamasas de espectro extendido en Escherichia coli, Klebsiella pneumoniae y Klebsiella oxytoca del Hospital Occidente de Kennedy.
|Published (Last):||8 January 2006|
|PDF File Size:||20.92 Mb|
|ePub File Size:||11.22 Mb|
|Price:||Free* [*Free Regsitration Required]|
Risk factors for extended-spectrum beta-lactamase positivity in uropathogenic Escherichia coli isolated from community-acquired urinary tract infections.
There was a problem providing the content you requested
Phylogenetic distribution of extraintestinal virulence-associated traits in Escherichia coli. Las infecciones del tracto urinario Betalacfamasas son frecuentes en la comunidad.
Dissemination of high-risk clones of extensively drug-resistant Pseudomonas aeruginosa in colombia. A case-control study in a French teaching hospital. ESBL production was confirmed by both methods in 47 Enterobacteriaceae9. Open in a separate window. International prospective study of Klebsiella pneumoniae bacteremia: Urinary tract infections UTI are common in the community.
Among clinical isolates of Enterobacteriaceae Un total de 2. National Center for Biotechnology InformationU. Resultados Un total de 2.
Services on Demand Article. Cecilio Baez Campus Universitario – U. Of the recruited patients, had a positive urine culture, of which grew E. The frequency obtained is lower than rates reported in neighboring countries, which could be explained by the fact that most of the begalactamasas were from outpatients.
Emergence of CTXMproducing strains causing urinary tract infections. Increased resistance to first-line agents among bacterial pathogens isolated from urinary tract infections in Latin America: A multinational survey of risk factors for infection with extended-spectrum beta-lactamase-producing enterobacteriaceae in nonhospitalized patients. However, information of resistant isolates in this context is limited in Latin America.
Mem Inst Oswaldo Cruz. Infect Control Hosp Epidemiol. Nursing homes as a reservoir of extended-spectrum beta-lactamase ESBL -producing ciprofloxacin-resistant Escherichia coli.
Resultados De los 2.
Escherichia coli portador de betalactamasas de espectro extendido: resistencia
Ann Clin Betalactamaszs Sci. Analysis of resistance of urinary cultures —, Roosevelt Hospital, Guatemala City. A case-control study was conducted between August and December of in three Colombian tertiary-care institutions. Waging war against uropathogenic Escherichia coli: Enferm Infecc Microbiol Clin.
All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License. ESBL confirmatory test, antibiotic susceptibility, and molecular epidemiology were performed in these E.
Los aislados de E. Widespread dissemination of CTX-M 15 genotype extended spectrum beta-lactamase producing Enterobacteriaceae among patients presenting to community hospitals in Southeastern United States. Expert Rev Anti Infect Ther.
Community infections caused by extended-spectrum beta-lactamase-producing Escherichia coli. Epidemiology of urinary tract infections: An emerging public-health concern.